Last week’s announcement by Sam Chun Dang Pharm that it will jointly develop and commercialize a weight-loss pill with Japanese drugmaker Daiichi Sankyo fueled a rally in the Korean company’s shares, making chairman Yoon Dae-in a billionaire.